(OP:NUMIF)

0.0163 -0.0037 (-18.50%)

Delayed Quote Updated: 3:26 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NUMIF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Psychedelic Stock Gainers And Losers From December 2, 2022 ↗

December 02, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From December 1, 2022 ↗

December 01, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 30, 2022 ↗

November 30, 2022

Via Benzinga

Numinus Wellness Inc. Reports Q4 2022 and Annual Results

November 30, 2022

Q4 2022 revenues grew 643% year-over-year to $4.2 million Q4 2022 gross margin grew to 31.5%, generated $1.3 million of gross profit Completed acquisition of Novamind, positioning Numinus as a leading,...

Via PressReach

Numinus Wellness Inc.'s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2M ↗

November 29, 2022

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, reported its financial results...

Via Benzinga

Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

November 29, 2022

Via Benzinga

Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

November 28, 2022

Via Benzinga

Psychedelic Drug Stocks Index Has A Good Week ↗

November 27, 2022

We track six psychedelic stocks researching the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances.

Via Talk Markets

Psychedelic Stock Gainers And Losers From November 25, 2022 ↗

November 25, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 24, 2022 ↗

November 24, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 23, 2022 ↗

November 23, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 22, 2022 ↗

November 22, 2022

Via Benzinga

Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions ↗

November 22, 2022

Bienstar Wellness Brasil Ltda., a subsidiary of Bienstar Wellness Corp., has entered into a joint venture agreement with Dr. Sun Clinic, a Brazil-based clinic with more than 30 years of experience...

Via Benzinga

Psychedelic Stock Gainers And Losers From November 21, 2022 ↗

November 21, 2022

Via Benzinga

Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

November 18, 2022

Via Benzinga

Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

November 17, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 16, 2022 ↗

November 16, 2022

Via Benzinga

GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

November 15, 2022

Via Benzinga

Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8% ↗

November 14, 2022

We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...

Via Talk Markets

Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today ↗

November 10, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05

Via Benzinga

Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

November 09, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From November 8, 2022 ↗

November 08, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14

Via Benzinga

Compass Pathways, Allied Among Top Psychedelic Movers Of Today ↗

November 07, 2022

GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44

Via Benzinga

Psychedelic Stock Gainers And Losers From November 3, 2022 ↗

November 03, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27

Via Benzinga

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗

November 02, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS:

Via Benzinga

Psychedelic Therapy Frontiers Podcast Is Back, Check Out Upcoming Episodes ↗

November 01, 2022

Mental health care company Numinus Wellness (OTCQX: NUMIF) is re-launching its "Psychedelic Therapy Frontiers" podcast series dedicated to exploring the psychedelics renaissance and cultivating mind,...

Via Benzinga

Mental Health Provider Expands Psychedelic-Assisted Therapy For Chronic & Serious Medical Illnesses ↗

October 28, 2022

Numinus Wellness Inc. (OTCQX: NUMIF) announced the launch of its new clinical program, ketamine for chronic and serious medical illness, to be first introduced at Utah, BC and Quebec clinics and then...

Via Benzinga

What Are The Best Psychedelic-Assisted Therapy Clinics In The World? Here Are 5 To Check Out ↗

October 28, 2022

Psychedelic-Assisted Therapy, or PAT, is the type of treatment in which the delivery of a psychedelic substance -i.e.

Via Benzinga

Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness

October 28, 2022

a documentary following the journey of a patient undergoing psychedelic-assisted therapy to treat end-of-life distress. Additionally, since Numinus'

Via PressReach

Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today ↗

October 27, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.